Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expenses
$7.59M
Quarterly · Period ending: · USD
ARMP R&D Expenses
Latest reported$7.59Mperiod ending
Latest reported$7.59Mperiod ending
ARMP Quarterly R&D Expenses ($0.00 → $7.59M)
Quarterly R&D Expenses
High-resolution chart · PNG
ARMP r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 3,200,000 | |
| 3,500,000 | |
| 3,100,000 | |
| 3,300,000 | |
| 3,100,000 | |
| 3,100,000 | |
| 3,600,000 | |
| 2,400,000 | |
| 2,400,000 | |
| 2,300,000 | |
| 1,900,000 | |
| 2,000,000 | |
| 2,000,000 | |
| 1,800,000 | |
| 1,900,000 | |
| 1,700,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |